AngioDynamics (ANGO) to Acquire RadiaDyne, Boost Oncology
AngioDynamics' (ANGO) agreement to acquire RadiaDyne is expected to close by the end of September. The Radi.....»»
AngioDynamics (ANGO) to Acquire RadiaDyne, Boost Oncology
AngioDynamics' (ANGO) agreement to acquire RadiaDyne is expected to close by the end of September. The Radi.....»»
AngioDynamics to acquire RadiaDyne
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Recap: AngioDynamics Q3 Earnings
Shares of AngioDynamics (NASDAQ:ANGO) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share were up 100.00% year over year to $0.02, which beat the estimate of ($0.02). read more.....»»
Recap: AngioDynamics Q3 Earnings
Shares of AngioDynamics (NASDAQ:ANGO) jumped over 7% after the .....»»
AngioDynamics is Now Oversold (ANGO)
Dividend Channel.....»»
Nokia to acquire optical networking tech firm Elenion
Finnish telecom networks maker Nokia Oyj said on Wednesday it has agreed to acquire privately-held U.S.-based company Elenion Technologies to boost its optical networking business and broaden its offering to telecoms operators......»»
AngioDynamics Becomes Oversold (ANGO)
Dividend Channel.....»»
Predictive Oncology signs LOI to acquire Quantitative Medicine
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AngioDynamics" latest acquisition will boost $95 million business line
It is the latest in a string of acquisitions for AngioDynamics as chief exec Jim Clemmer refocuses the medical device maker by "carving out significant space in larger and faster growing markets.".....»»
5 Stocks To Watch For January 7, 2020
Some of the stocks that may grab investor focus today are: Wall Street expects AngioDynamics, Inc. (NASDAQ: ANGO) to report quarterly earnings at $0.02 per shar.....»»
Merck to acquire ArQule for $20 per share in cash or about $2.7 billion
Merck & Co. Inc. said Monday it has entered an agreement to acquire ArQule Inc. for $20 a share in cash or an equity value of about $2.7 billion. The deal is expected to close in the first quarter of 2020 and to boost Me.....»»
France"s Sanofi to buy Synthorx for $2.5B
The move helps Sanofi boost its immuno-oncology pipeline......»»
Oversold Conditions For AngioDynamics (ANGO)
Dividend Channel.....»»
WebMD buying Merck subsidiary to boost reach
Manhattan-based WebMD said Monday that it has agreed to acquire Reading, Mass.–based Aptus Health, which helps companies engage health care professionals and consumers through digital channels and... To view the full story, click the title link......»»
AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q1 2020 Results - Earnings Call Transcript
AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q1 2020 Results - Earnings Call Transcript.....»»
AngioDynamics Enters Oversold Territory (ANGO)
Dividend Channel.....»»
UAB Health System expands partnership with Toronto company
UAB Health System has expanded a partnership with a Toronto-based company that will benefit patients undergoing cardiac surgeries, thoracic surgeries and gynecologic oncology procedures. UAB will boost the SeamlessMD platform across more departme.....»»
AngioDynamics (ANGO) Presents At Canaccord Genuity Growth Conference - Slideshow
AngioDynamics (ANGO) Presents At Canaccord Genuity Growth Conference - Slideshow.....»»